Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Regents of the University of CA”

3,501 pharma patents match "Regents of the University of CA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,501
Index total 30,257
Page 97 / 146

Quick answer

This filtered view shows 3,501 pharmaceutical patents matching "Regents of the University of CA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,501 results for “Regents of the University of CA” · 30,257 patents in full index Clear search

  1. US 8101158

    Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  2. US 8097701

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  3. US 8093274

    Inhibitors of protein prenyltransferases

    The Regents of the University of California · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  4. US 8088908

    Humanized anti-prostate stem cell antigen monoclonal antibody

    The Regents of the University of California · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  5. US 8084016

    Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products

    The Regents of the University of California · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  6. US 8080256

    Endophytic fungi from Pteromischum sp. plant, compounds and methods of use

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  7. US 8080527

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  8. US 8080523

    Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  9. US 8075904

    High aspect ratio template and method for producing same for central and peripheral nerve repair

    The Regents of the University of California · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  10. US 8071535

    Guanidinium derivatives for improved cellular transport

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  11. US 8071107

    Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  12. US 8071074

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  13. US 8067460

    5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel

    The Regents of the University of California · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  14. US 8058295

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  15. US 8053412

    NELL-1 peptides

    The Regents of the University of California · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  16. US 8048844

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  17. US 8048851

    Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  18. US 8048646

    NELL peptide expression systems and bone formation activity of NELL peptide

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  19. US 8043820

    Diagnostic methods for the detection of risk of autistic spectrum disorder

    The Regents of the University of California · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  20. US 8044026

    Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition

    The Regents of the University of California · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  21. US 8034556

    Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity

    The Regents of the University of California · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  22. US 8034821

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  23. US 8029826

    Chlorite in the treatment of neurodegenerative disease

    The Regents of the University of California · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  24. US 8030297

    Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.